These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 6488489)

  • 1. Release of endogenous catecholamines in the ischemic myocardium of the rat. Part A: Locally mediated release.
    Schömig A; Dart AM; Dietz R; Mayer E; Kübler W
    Circ Res; 1984 Nov; 55(5):689-701. PubMed ID: 6488489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradoxical role of neuronal uptake for the locally mediated release of endogenous noradrenaline in the ischemic myocardium.
    Schömig A; Dart AM; Dietz R; Kübler W; Mayer E
    J Cardiovasc Pharmacol; 1985; 7 Suppl 5():S40-4. PubMed ID: 2410734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonexocytotic release of endogenous noradrenaline in the ischemic and anoxic rat heart: mechanism and metabolic requirements.
    Schömig A; Fischer S; Kurz T; Richardt G; Schömig E
    Circ Res; 1987 Feb; 60(2):194-205. PubMed ID: 3568291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two different mechanisms of noradrenaline release during normoxia and simulated ischemia in human cardiac tissue.
    Kurz T; Richardt G; Hagl S; Seyfarth M; Schömig A
    J Mol Cell Cardiol; 1995 May; 27(5):1161-72. PubMed ID: 7473774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Release of endogenous catecholamines in the ischemic myocardium of the rat. Part B: Effect of sympathetic nerve stimulation.
    Dart AM; Schömig A; Dietz R; Mayer E; Kübler W
    Circ Res; 1984 Nov; 55(5):702-6. PubMed ID: 6488490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catecholamines in myocardial ischemia. Systemic and cardiac release.
    Schömig A
    Circulation; 1990 Sep; 82(3 Suppl):II13-22. PubMed ID: 2203558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular sodium and chloride depletion enhances nonexocytotic noradrenaline release induced by energy deficiency in rat heart.
    Kurz T; Schömig A
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):265-9. PubMed ID: 2812038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sympatho-adrenergic activation of the ischemic myocardium and its arrhythmogenic impact.
    Schömig A; Richardt G; Kurz T
    Herz; 1995 Jun; 20(3):169-86. PubMed ID: 7635399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal sodium homoeostatis and axoplasmic amine concentration determine calcium-independent noradrenaline release in normoxic and ischemic rat heart.
    Schömig A; Kurz T; Richardt G; Schömig E
    Circ Res; 1988 Jul; 63(1):214-26. PubMed ID: 3383376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol inhibits nonexocytotic noradrenaline release in myocardial ischemia.
    Richardt G; Lumpp U; Haass M; Schömig A
    Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):50-5. PubMed ID: 2314483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of digitalis glycosides on norepinephrine release in the heart. Dual mechanism of action.
    Kranzhöfer R; Haass M; Kurz T; Richardt G; Schömig A
    Circ Res; 1991 Jun; 68(6):1628-37. PubMed ID: 2036716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac sympathetic activity in myocardial ischemia: release and effects of noradrenaline.
    Schömig A; Richardt G
    Basic Res Cardiol; 1990; 85 Suppl 1():9-30. PubMed ID: 2091611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early intraneuronal mobilization and deamination of noradrenaline during global ischemia in the isolated perfused rat heart.
    Carlsson L; Graefe KH; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):508-18. PubMed ID: 3437922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ganglionic blockade on noradrenaline release and cell injury in the acutely ischemic rat myocardium.
    Abrahamsson T; Almgren O; Holmgren S
    J Cardiovasc Pharmacol; 1982; 4(4):584-91. PubMed ID: 6181332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonexocytotic noradrenaline release induced by pharmacological agents or anoxia in human cardiac tissue.
    Kurz T; Richardt G; Seyfarth M; Schömig A
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jun; 354(1):7-16. PubMed ID: 8832582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine inhibits exocytotic release of endogenous noradrenaline in rat heart: a protective mechanism in early myocardial ischemia.
    Richardt G; Waas W; Kranzhöfer R; Mayer E; Schömig A
    Circ Res; 1987 Jul; 61(1):117-23. PubMed ID: 3608108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium antagonists and cardiac noradrenaline release in ischemia.
    Richardt G; Haass M; Schömig A
    J Mol Cell Cardiol; 1991 Mar; 23(3):269-77. PubMed ID: 1880812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide Y differentiates between exocytotic and nonexocytotic noradrenaline release in guinea-pig heart.
    Haass M; Hock M; Richardt G; Schömig A
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov; 340(5):509-15. PubMed ID: 2615846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic requirements for release of endogenous noradrenaline during myocardial ischaemia and anoxia.
    Dart AM; Riemersma RA; Schömig A; Ungar A
    Br J Pharmacol; 1987 Jan; 90(1):43-50. PubMed ID: 3814923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of noradrenaline in myocardial ischemia--importance of local inactivation by neuronal and extraneuronal mechanisms.
    Carlsson L; Abrahamsson T; Almgren O
    J Cardiovasc Pharmacol; 1986; 8(3):545-53. PubMed ID: 2425171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.